Forgotten But Not Gone: Other Highs

March 5, 2018 by C. Scott McMillin

There’s an ongoing search among users for ways to either improve the high (which escalating tolerance threatens to steal away) or suppress the withdrawal symptoms.

Topics: , , ,


Opioid Epidemic Budget Exercise

March 1, 2018 by C. Scott McMillin

I think at this point, most law enforcement personnel would agree. They’ve concluded that, as the saying goes, this is one of those problems we “can’t arrest our way out of.”

Topics: ,


Strange Bedfellows in the Pharma Lobby

February 26, 2018 by C. Scott McMillin

It isn’t PhDs in the white lab coats who show up at your doctor’s office to provide false or misleading information about drug safety.

Topics: , ,


Two Perspectives on Pain

February 22, 2018 by C. Scott McMillin

We may be stuck relying on the soft stuff– therapy, support, behavior change, even spiritual growth– all those icky-squicky things that neuroscientists struggle to quantify.

Topics: , , , ,


Nature vs. Nurture Again

February 8, 2018 by C. Scott McMillin

We can’t predict in advance which user will turn out to be in which category, and frankly, neither can they.

Topics: , , ,


Secretary for Drug Crises?

February 1, 2018 by C. Scott McMillin

I thought that blue ribbon commission did a pretty good job with its 60 recommendations, but I haven’t seen much subsequent action, have you?

Topics: , ,


The Epidemic Rolls On…

January 11, 2018 by C. Scott McMillin

There are plenty of steps we could take, supported by research and common sense, that would produce measurable gains in a relatively short span.

Topics: , ,


Restorative Justice for Big Pharma?

January 4, 2018 by C. Scott McMillin

I think most people understand the concept of making amends for past misdeeds.

Topics: , ,


Beware Lookalikes

December 14, 2017 by C. Scott McMillin

It’s also not too difficult to create a ‘homemade’ variety using raw ingredients purchased on the dark web and a common pill press.

Topics: , , ,


In the News: Big Pharma’s Addiction Profits

December 4, 2017 by C. Scott McMillin

We watch and listen to Big Pharma execs on television and find ourselves thinking, are these guys so different from a street corner drug dealer?

Topics:


Subscribe to RecoverySI via Email


New Content